Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
about
Mouse models for radiation-induced cancersHZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary CarcinogenesisTwo-phase and family-based designs for next-generation sequencing studiesSecond malignant neoplasms and cardiovascular disease following radiotherapy.Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature reviewIonising radiation and cancer risks: what have we learned from epidemiology?Therapeutic radiation and the potential risk of second malignancies.Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudyRadiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology StudySecond solid cancers after radiotherapy for breast cancer in SEER cancer registries.Relation of risk of contralateral breast cancer to the interval since the first primary tumour.Whole breast and regional nodal irradiation in prone versus supine position in left sided breast cancer.Intensity modulated radiotherapy with fixed collimator jaws for locoregional left-sided breast cancer irradiation.Left-sided whole breast irradiation with hybrid-IMRT and helical tomotherapy dosimetric comparison.Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesDosimetric comparison for volumetric modulated arc therapy and intensity-modulated radiotherapy on the left-sided chest wall and internal mammary nodes irradiation in treating post-mastectomy breast cancerImaging dose in breast radiotherapy: does breast size affect the dose to the organs at risk and the risk of secondary cancer to the contralateral breast?Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer.On the Use of Optically Stimulated Luminescent Dosimeter for Surface Dose Measurement during RadiotherapyReproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE studyRisk of second cancer after initial treatment of breast cancer: An Osaka Cancer Registry Database study.Influence of different boost techniques on radiation dose to the left anterior descending coronary arteryAdjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Volumetric-modulated arc therapy for left-sided breast cancer and all regional nodes improves target volumes coverage and reduces treatment time and doses to the heart and left coronary artery, compared with a field-in-field technique.Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.Second malignant neoplasms following radiotherapy.Low-dose-area-constrained helical TomoTherapy-based whole breast radiotherapy and dosimetric comparison with tangential field-in-field IMRT.Prone breast forward intensity-modulated radiotherapy for Asian women with early left breast cancer: factors for cardiac sparing and clinical outcomes.Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy.Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysisStatistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancerVariation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEERSecondary malignancies across the age spectrum.Segmented photon beams technique for irradiation of postmastectomy patientsThe Feasibility Study of a Hybrid Coplanar Arc Technique Versus Hybrid Intensity-modulated Radiotherapy in Treatment of Early-stage Left-sided Breast Cancer with Simultaneous-integrated Boost.
P2860
Q26747129-FC5145F9-F539-44B9-A89B-B04CDE9B91CAQ26750868-1C4A44DD-00D7-4384-8ED8-9C7372C1F917Q26828744-F277A022-58EA-40E1-985B-BDDD6B19CADFQ26864522-B8E746AC-A51A-4FBD-B486-F90BD40EE4B8Q26999068-F8A3E55E-0C3E-47AD-8B08-6145AD74B810Q28395078-600461F2-610E-49A7-9A8C-A7F318F5DA1EQ30251822-26023D63-9AC8-4016-B461-9B1860C3D4E9Q30410984-0B5FE44E-08AA-4940-9F86-0F0A9EEFD047Q30423128-7321992E-712E-4B6E-8CDC-071211ED5615Q30427359-97443856-4B12-4D25-8D6A-149C5C2EBE1DQ30432746-97081ED5-B5F9-4F26-AD83-20090A4C4C79Q30436439-9323BB0F-5D80-4E47-BE5C-BDC23B62B5CAQ33620015-1EA5BE2B-B8D1-4D06-8BFA-BE87B115DC88Q33620146-9EB372BD-7C74-4522-B0CA-3485FD2659D1Q33733680-3D74A379-A946-420C-BD6C-2A70F874AD01Q33779446-FB7701D7-B4FC-4E45-98FF-68FECA5DB964Q34003177-D5567CC9-32C5-42A3-B1B2-44B141DF362DQ34371336-7F32A6AC-DAC1-4296-80FB-6CF5E385D98CQ34521998-190C760E-580C-483B-8C20-B60AA3D988E7Q34914474-41BB5037-E7E7-4AB6-A516-7FD485C3CF50Q35184833-8E60681B-8B9A-4F24-B01F-460EEF0167DEQ35192030-A6F0D250-C39A-4E9A-9038-0864FE45F4EDQ35565798-35EB2596-0E43-42E1-BA26-5BB501967E8BQ35655991-8C14580D-1CA7-4577-A8A8-8145CB411B4DQ36089820-8D93D32D-D874-44F4-BF69-65D7AA08D9FDQ36126599-D06C4529-6503-4738-A417-1956BE1FDE07Q36166891-B1671095-C856-4C38-9FC4-C1348A091C31Q36210166-7CA64711-937B-4164-9E74-74BEAF992646Q36234752-92C620A4-8809-4433-B058-B125EE8E9035Q36441553-41D592FA-38C2-4E0E-8F7E-9B6F5D50B2DFQ36538754-EC46BA1D-0A2C-4F26-B862-BCE2768E2F34Q37137579-D94EB5F5-136A-4BD3-88D2-54D88AEBC594Q37154072-DE204128-CA1E-4F76-B57D-629DCB1E3E2EQ37212677-6CC51DE4-E18D-45C7-93CB-C2045B40F904Q37274154-CF1F87CD-7B2F-4D12-8BDC-5FF0AFF4B109Q37308477-00B1EDA2-62BC-487B-901C-DA8250277EEEQ37379588-FD7092E7-2FB9-4AAD-A6F8-C7210B5CAB4EQ37379773-F2C36441-B28B-430E-B941-427467E51DEAQ37392134-5CEA815E-A280-4760-9A9F-D26DE1AF0060Q37725996-46C0A163-AD8B-4C59-B41E-8CBB598728BC
P2860
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose to the contralateral brea ...... st cancer in the WECARE study.
@en
Dose to the contralateral brea ...... st cancer in the WECARE study.
@nl
type
label
Dose to the contralateral brea ...... st cancer in the WECARE study.
@en
Dose to the contralateral brea ...... st cancer in the WECARE study.
@nl
prefLabel
Dose to the contralateral brea ...... st cancer in the WECARE study.
@en
Dose to the contralateral brea ...... st cancer in the WECARE study.
@nl
P2093
P2860
P50
P1476
Dose to the contralateral brea ...... st cancer in the WECARE study.
@en
P2093
Barry S Rosenstein
Bryan M Langholz
Charles F Lynch
Duncan C Thomas
John D Boice
Jonine L Bernstein
Kathleen E Malone
Marilyn Stovall
Marinela Capanu
Michael Andersson
P2860
P304
P356
10.1016/J.IJROBP.2008.02.040
P407
P577
2008-06-14T00:00:00Z